China cancer monoclonal antibodies market is estimated to grow at a CAGR of 11.6% during the forecast period. Rising new cancer incidences is the major factor driving the adoption of monoclonal antibodies therapeutics in the country. As per the World Health Organization (WHO), nearly 4.3 million new cancer incidences were reported in 2018. Lung cancer […]
